3,353
views
1
recommends
+1 Recommend
1 collections
    2
    shares

      CVIA now indexed by SCOPUS from February 2024. CVIA received its first Journal Impact Factor (0.5) in the 2023 Journal Citation Reports Release. 

      Interested in becoming a CVIA published author?

      • Platinum Open Access with no APCs. 
      • Fast peer review/Fast publication online after article acceptance.

      Submissions should be made electronically at: https://mc04.manuscriptcentral.com/cvia-journal.

      Please refer to the Author Guidelines at https://cvia-journal.org/instructions-to-authors/ before submission.

       

      scite_
       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Spontaneous Heparin-Induced Thrombocytopenia Presenting as Concomitant Bilateral Cerebrovascular Infarction and Acute Coronary Syndrome

      case-report
      Bookmark

            Abstract

            Background: Spontaneous heparin-induced thrombocytopenia is a pro-thrombotic syndrome in which anti-heparin antibodies develop without heparin exposure.

            Case presentation: A 78-year-old man who underwent a successful lumbar laminectomy presented to the hospital 5 days after discharge for stroke-like symptoms and was found to have acute infarcts of the bilateral frontal lobes. The patient was found to be severely thrombocytopenic and was incidentally found to have an inferior wall myocardial infarction. Further investigation led to the diagnosis of bilateral lower extremity deep vein thromboses. His overall clinical presentation prompted a detailed hematologic workup that indicated positivity for heparin-induced thrombocytopenia despite no previous exposure to heparin products.

            Conclusions: This case illustrates a patient with no prior lifetime heparin exposure who underwent laminectomy with subsequent development of acute infarcts of the bilateral frontal lobes, an inferior wall myocardial infarction, and bilateral lower extremity deep vein thromboses, with concern for sequelae of spontaneous heparin-induced thrombocytopenia.

            Main article text

            Introduction

            Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder in which IgG-mediated platelet activation leads to thrombosis and thrombocytopenia, whose presentation may include arterial or venous thrombosis [1, 2]. Evaluation of HIT requires a quantitative enzyme immunoassay measuring the antibodies that bind PF4-heparin complexes [3], but confirmatory testing with functional assays, such as serotonin release assays, is typically recommended. Recently, patients have been found to develop HIT, including the formation of HIT antibodies, without any known exposure to heparin products [4]. Spontaneous HIT syndrome has been identified predominantly in post-orthopedic procedures [5, 6] but has also been described in post-infectious scenarios [4].

            Case Report

            A 78-year-old man who initially presented for laminectomy with posterior lumbar decompression of L2-S1 was readmitted to the hospital 5 days after discharge with worse right than left lower extremity weakness, vertigo, and slurred speech, thus prompting concern for a cerebrovascular accident (CVA). The patient had a history of essential hypertension, insulin-dependent diabetes mellitus, and mild aortic stenosis. Head computed tomography (CT) without contrast showed no visible acute intracranial abnormality, and spinal CT without contrast showed soft tissue and possible fluid density within the previous surgical bed dorsal to the spinal canal. Follow-up brain magnetic resonance imaging (MRI) without contrast was performed to further evaluate neurologic deficits and showed remarkable findings of three small acute infarcts involving the left frontal lobe, and a single punctate acute infarct involving the right frontal lobe with underlying atrophy and chronic ischemic disease. The infarcts were deemed to be small and not to require acute stroke intervention at the initial time of presentation. Although the patient was not experiencing chest pain or shortness of breath at admission, he was incidentally noted to have ST elevations in the inferior leads suggestive of inferior ST-elevation myocardial infarction (MI) on his initial admission electrocardiogram (ECG). The initial differential diagnoses for the ECG included spontaneous MI secondary to coronary embolism, spontaneous MI secondary to direct thrombus formation from plaque rupture, and spontaneous MI secondary to vasospasm. A 12-lead ECG indicated sinus bradycardia with heart rate of 56 beats per minute with atrioventricular dissociation, thus prompting concern for third degree heart block and ST-elevations in leads II, III, and aVF with reciprocal ST-depressions in leads V2 and V3 (Figure 1). Troponin I peaked at 34 ng/mL. A transthoracic echocardiogram demonstrated a left ventricular ejection fraction of 55–60%, and mild basal and sigmoid septal hypertrophy with no wall motion abnormalities. His platelet count had decreased from 343,000/μL to 12,000/μL five days after laminectomy and surgical lumbar decompression. Upon evaluation of the ECG suggesting ST-elevation MI, the interventional cardiology department was consulted for left heart catheterization. However, in the setting of severe thrombocytopenia, likely acute CVA, recent spinal surgery, and the absence of hemodynamic instability, intervention was deferred, because the risk of bleeding was deemed too high. He was empirically initiated on high-dose statin therapy and medically managed in the cardiac step-down unit.

            Figure 1

            Admission Electrocardiogram.

            Sinus bradycardia with atrioventricular dissociation and ST elevations in leads II, III, and aVF with reciprocal ST-depressions in leads V2 and V3.

            In the setting of lower extremity edema on admission physical examination, the patient also underwent bilateral lower extremity venous doppler imaging, which revealed bilateral lower extremity deep vein thrombosis (DVT). Owing to the patient’s thrombocytopenia with evidence of DVT, stroke, and MI, we requested a heparin induced platelet antibody and serotonin release assay for low molecular weight heparin and unfractionated heparin (UFH), which yielded positive results for heparin induced platelet antibody, and a UFH serotonin release assay with indeterminate low molecular weight heparin serotonin release assay. The differential diagnosis before the HIT workup included immune-thrombocytopenic purpura, for which the patient was initiated on 1 mg/kg of prednisone. Because the patient was not anticoagulated, owing to recent spinal surgery with neurosurgical concerns regarding spinal bleeding, an IVC filter was inserted to decrease the risk of pulmonary embolism from his bilateral DVTs. Heparin products were avoided during his hospitalization, and the patient was initiated on bivalirudin for therapeutic anticoagulation after his platelet count exceeded 50,000/μL. At the time of discharge, he was switched to apixaban and continued prednisone for empiric therapy.

            Thorough chart review indicated no exposure to heparin during the intraoperative and post-operative periods. Further evaluation with abdominal/pelvic CT was performed to rule out occult malignant etiologies of hypercoagulability, and none were detected. Bone marrow aspirate indicated hypercellular trilineage hematopoietic bone marrow with progressive maturation and increased megakaryocytes favoring a reactive process indicative of increased cellular production (Figure 2).

            Figure 2

            Pathology Slide from Bone Marrow Aspirate: Immunohistochemical Stain at 20x Magnification.

            Hypercellular trilineage hematopoietic bone marrow with progressive maturation and increased megakaryocytes.

            After the platelet count reached 50,000/μL, and the risk of hemorrhagic conversion of CVA was determined to be small, a left heart catheterization was performed, which showed mild non-obstructive coronary artery disease (Video 1). Follow-up cardiac MRI demonstrated sequelae of transmural, nonviable myocardium involving the inferior wall extending from the apex to the base, with involvement of the inferolateral and inferoseptal walls at the level of the left ventricular base, and a calculated left ventricular ejection fraction of 49% (Video 2). The territory of nonviable myocardium found on the cardiac MRI was consistent with the patient’s initial clinical presentation of inferior STEMI, which was thought to be in the setting of a thrombus in the right coronary artery that had probably resolved by the time of the left heart catheterization.

            On day nine of hospitalization, he had an episode of ventricular tachycardia, which was unresponsive to amiodarone. He subsequently required defibrillation with transient pulseless electrical activity arrest and achieved return of spontaneous circulation after 2 minutes of cardiopulmonary resuscitation. He was initiated on a lidocaine drip and had no further episodes of ventricular tachycardia. Before discharge, he underwent successful implantation of a dual-chamber implantable cardioverter defibrillator and was continued on amiodarone.

            Discussion

            Heparin-induced thrombocytopenia is clinically characterized by thrombocytopenia and hypercoagulability due to platelet-activating anti-platelet 4 heparin antibodies. Although the pattern of thrombosis in HIT typically occurs on the venous side, arterial thromboembolic complications have been documented [2], and cases of coronary thrombosis have been reported in association with HIT. These instances have presented as acute coronary syndrome and at times have led to life-threatening emergencies. In addition, growing evidence of a heparin-induced thrombocytopenia mimicking disorder is being reported. This disorder has a clinically similar presentation to that of heparin-induced thrombocytopenia, despite a lack of any preceding exposure to heparin; therefore, it has been termed spontaneous heparin-induced thrombocytopenia syndrome. Two primary subtypes of spontaneous HIT syndrome have been described: (a) post-surgical (primarily orthopedic interventions) and (b) medical (typically post-infectious). Although our case is in the former category of post-orthopedic surgical intervention with no likely infectious etiology, the SARS-CoV-2 pandemic might result in an increase in unexplained cases of pro-thrombotic states in the future, which may require additional evaluation to rule out etiologies such as spontaneous HIT syndrome (our patient tested negative for COVID-19 on initial presentation).

            Why spontaneous HIT syndrome is associated with orthopedic surgeries remains unclear, but in orthopedic knee replacements, polyanionic glycosaminoglycans from the joint have been hypothesized to be released into the systemic circulation, and a tourniquet release might even deliver a bolus to the body [7]. Polyanionic glycosaminoglycans may mimic UFH in molecular structure, bind platelet factor 4, and stimulate the antibody response, thus leading to the cascade of intravascular platelet activation, aggregation, and thrombosis seen in heparin-induced thrombocytopenia.

            Although a case of spontaneous thrombosis in a previously untreated native coronary artery in the setting of HIT has been reported [8], this thrombosis has been documented primarily in the settings of previous coronary intervention, stenting, or coronary bypass graft [9, 10]. These reports suggest that early recognition and treatment of coronary thrombosis in patients with suspicion for HIT should be considered in both untreated and treated coronary vasculature.

            We hypothesize that spontaneous HIT triggered the formation of microthrombi in both the arterial and venous circulations, and caused the manifestations of the CVA, DVT, and MI. Another possibility might have been thrombotic events from a patent foramen ovale; however, negative agitated saline contrast echocardiography did not suggest this mechanism of action.

            Three months after discharge, the patient remained asymptomatic from a cardiovascular standpoint, and his platelet count ranged from 208,000 to 269,000/μL, with no further hypercoagulable sequelae.

            Conclusion

            In summary, we report a case of acute coronary syndrome in a patient with presumed spontaneous HIT syndrome post-laminectomy. The onset of hypercoagulable clinical findings shortly after this patient’s spinal surgical intervention indicated that clinical vigilance is needed in the evaluation of post-thrombotic processes. A patient presenting with a hypercoagulable state in the postoperative setting without heparin exposure may have spontaneous HIT syndrome, manifested through various clinical mechanisms including acute coronary syndrome by means of microvascular obstruction. To date, only a few cases of spontaneous HIT syndrome have been reported, and the recommended treatments are mainly direct oral anticoagulants, direct thrombin inhibitors, or warfarin.

            Ethic Statement

            The patient provided his written informed consent to participate in this study. Written informed consent was obtained from the individual for the publication of any potentially identifiable images or data included in this article.

            Glossary

            Abbreviations

            CT

            computed tomography

            DVT

            deep vein thrombosis

            ECG

            electrocardiogram

            HIT

            heparin-induced thrombocytopenia

            MI

            myocardial infarction

            UFH

            unfractionated heparin

            Statement of Authorship

            All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. Jong Kun Park collected the data, reviewed the literature, and drafted the manuscript. Araba Ofosu-Somuah contributed to data interpretation and organization. Ilan Vavilin, Jacob Zaemes, Raghav Gattani, Camila Sahebi, and Alexander Truesdell revised the manuscript.

            Conflicts of Interests

            The authors have no financial or personal conflicts of interests to declare.

            Citation Information

            References

            1. , . Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia. Ther Adv Hematol 2012;3:237–51.

            2. . Heparin-induced thrombocytopenia. N Engl J Med 2015;373:1883–4.

            3. , , , . The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2010;8:216–8.

            4. , , , . Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder. Blood 2014;123:3651–4.

            5. , , . A patient with ‘spontaneous’ heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement. Blood Coagul Fibrinolysis 2011;22:73–5.

            6. , . Spontaneous heparin-induced thrombocytopenia and venous thromboembolism following total knee arthroplasty. Case Rep Hematol 2017;2017:4918623.

            7. , . “Spontaneous” heparin-induced thrombocytopenia and thrombosis after total knee arthroplasty: a report of 2 cases. Arthroplast Today 2021;9:50–2.

            8. , , . Native coronary artery thrombosis in the setting of heparin-induced thrombocytopenia: a case report. Eur Heart J Case Rep 2018;2:1–5.

            9. , , . Coronary artery stent thrombosis associated with heparin-induced thrombocytopenia: case report and review of the literature. J Interv Cardiol 2005;18:131–7.

            10. , , , . Serious acute coronary thrombosis associated with heparin-induced thrombocytopenia in off-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2010;11:188–90.

            Supplementary Material

            Supplementary videos for this paper are available at the following link. https://cvia-journal.org/supplementary-figures-2/.

            Author and article information

            Journal
            CVIA
            Cardiovascular Innovations and Applications
            CVIA
            Compuscript (Ireland )
            2009-8782
            2009-8618
            11 February 2023
            : 7
            : 1
            : e980
            Affiliations
            [1] 1The University of Texas Health Science Center at Houston, Houston, TX, USA
            [2] 2MedStar Georgetown University Hospital, Washington D.C., USA
            [3] 3Inova Heart and Vascular Institute, Falls Church, VA, USA
            [4] 4Inova Fairfax Hospital Department of Hematology and Oncology, Falls Church, VA, USA
            Author notes
            Correspondence: Jong Kun Park, MD, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 6431 Fannin MSB 1.134, Houston, TX, 77030, USA, Phone: 352-222-7891, E-mail: jongkun.park@ 123456uth.tmc.edu
            Article
            cvia.2023.0007
            10.15212/CVIA.2023.0007
            1ba965a6-8c44-4b02-934c-a27a99e3b57d
            Copyright © 2023 Cardiovascular Innovations and Applications

            This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 Unported License (CC BY-NC 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc/4.0/.

            History
            : 19 November 2022
            : 19 December 2022
            : 17 January 2023
            Page count
            Figures: 2, References: 10, Pages: 5
            Categories
            Case Study/Report

            General medicine,Medicine,Geriatric medicine,Transplantation,Cardiovascular Medicine,Anesthesiology & Pain management
            cerebrovascular infarction,deep vein thrombosis,Acute coronary syndrome,spontaneous heparin-induced thrombocytopenia,myocardial infarction

            Comments

            Comment on this article